Spyre Therapeutics Revenue and Competitors

Location

$32M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Spyre Therapeutics's estimated annual revenue is currently $13M per year.(i)
  • Spyre Therapeutics's estimated revenue per employee is $155,000
  • Spyre Therapeutics's total funding is $32M.

Employee Data

  • Spyre Therapeutics has 84 Employees.(i)
  • Spyre Therapeutics grew their employee count by 75% last year.

Spyre Therapeutics's People

NameTitleEmail/Phone
1
Senior EA to the Chief Medical OfficerReveal Email/Phone
2
Chief Intellectual Property CounselReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Chief Technical OfficerReveal Email/Phone
5
Chief Legal Officer and Corporate SecretaryReveal Email/Phone
6
Chief Medical OfficerReveal Email/Phone
7
Chief Medical OfficerReveal Email/Phone
8
SVP, PeopleReveal Email/Phone
9
VP, Corporate ControllerReveal Email/Phone
10
SVPReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Spyre Therapeutics?

Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease.

keywords:N/A

$32M

Total Funding

84

Number of Employees

$13M

Revenue (est)

75%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.8M840%$23M
#2
$33.6M8422%$20.2M
#3
$10.9M84-1%$13.6M
#4
$15M842%$173.2M
#5
$18.5M8429%N/A